MedDay is a French biotech company in the treatment of neuro-metabolic diseases. Founded in 2011 by Frédéric Sedel and Guillaume Brion, MedDay relies on the work of Dr Frédéric Sedel, a neuroscientist at La Pitié Salpêtrière Hospital (Paris), who has...
04.15.2013
Research applications
One of the most exciting challenges in neurosciences is to understand how the brain encodes and stores new information from the environment in order to produce adequate changes in behaviour. In the past, the prevailing view concerning the cellular...
02.25.2013
Research, science & health
Paris, on January 21st 2013 A new convention between the Institut du Cerveau - ICM and IPGM (Institution of social welfare member of Groupe KLESIA), was signed in the premises of the Institute, situated in Paris. This signature was made in the...
01.21.2013
Support
PRESS CONFERENCE AT Paris Brain Institute
01.18.2013
Support
Nomination of Professor Alexis Brice as General Manager of the Brain & Spine Institute (Institut du Cerveau - ICM)
04.25.2012
Institutional
In the context of the second week of industry, Eric Besson, the minister of industry visited the site of Institut du Cerveau - ICM.
03.23.2012
Institutional
Institut du Cerveau et de la Moelle épiniѐre (Institut du Cerveau - ICM) and Pfizer have announced a three-year scientific collaboration to investigate the fundamental mechanisms of certain neurodegenerative diseases, including Alzheimer’s, Parkinson...
02.01.2012
Institutional
An international clinical trial in Creutzfeldt-Jakob disease was conducted in France and Italy. Led in France by reasearchers from the Brain and Spinal institute (Jean Philippe Brandel and Stéphane Haïk), this study opens new perspectives for the...
01.29.2011
Research, science & health
